Recent Class Actions Expose Data Privacy Risk in Acquisitions in Healthcare and Healthcare AI

Short summary

Recent class actions against Tempus AI highlight the data privacy risks when healthcare companies are acquired for their data to train AI models. The 23andMe bankruptcy and TTAM acquisition further illustrate gaps in federal regulation of direct-to-consumer health data. Plaintiffs are invoking state genetic privacy laws and common law claims to challenge unauthorized use of patient data in AI training and licensing.

• •Tempus AI sued for using acquired genetic data to train AI without consent
• •23andMe bankruptcy shows regulatory gaps for direct-to-consumer health data
• •State laws like GIPA and CMIA emerging as key tools for plaintiffs in healthcare AI data cases

Generated with AI, which can make mistakes.